A. T. Namai-r, . Murakami-y, . Watanabe-m, . Matsui-t, . Nishimura-a et al., Rapid induction of peroxisome proliferator-activated receptor gamma expression in human monocytes by monosodium urate monohydrate crystals, Arthritis Rheum, vol.48, pp.2-3, 2003.

A. M. Lyons-j, . Kabbinavar-f, . Bray-m, . Snow-8, . Ayala-r et al., Overexpression ofAkt2/ protein kinase Bb leads to up-regulaton ofbetal integrins, increased invasion, and metastasis of human breast and ovarian cancer cells Cancer Res, pp.196-206, 2003.

B. C. Mansouri-r, F. J. , S. B. , and G. , Diflerent ways to regulate the PPARalpha stability, Biochem Biophys Res Commun, vol.319, pp.663-70, 2004.

B. O. Folifelle-f, D. M. Scotto-c, and W. , Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, beta , and -gamma in the adult rat Endocrinologt, pp.996-354

C. D. , M. H. , H. H. , K. S. Huang-s, S. B. et al., Regulation of transcription by a protein methyltransferase Science, I 999, pp.2-74

C. P. Guan-h, L. M. , and L. , PPARy regulates adipocyte cholesterol metabolism via oxidized LDL receptorl, J Clin Invest, vol.115, pp.2244-56, 2005.

C. P. Domenjoud-l, D. M. , M. H. , S. H. , and D. , The human semaphorin 68 gene is down regulated by PPARs Genomics, pp.3-4, 2004.

C. E. Drane-p, L. C. , D. K. Braun-c, H. J. , and E. J. , Dysregulation of the peroxisome proliferator-activated receptor target genes by XPD mutations, Mol Cell Biol, vol.25, pp.6065-76, 2005.

P. Do\ryell, I. J. , A. D. Peterson-v, N. D. , and L. , p300 functions as a coactivator for the peroxisome proliferator-activated receptor alpha, J Biol Chem, vol.272, pp.33435-33478, 1997.

D. C. Krey-g, . Keller-h, H. G. Givel-f, and W. , Control of the peroxisomal p-oxidation pathway by a novel family of nuclear hormone receptors Cell, pp.879-87, 1992.

D. R. Gupta-r, . Brockman-j, K. S. Reddy-b, and L. M. , The nuclear eicosanoid receptorc, PPARgamma, is aberrantly expressed in colonic cancers Carcinogenesis, I 998, pp.49-54

F. L. , A. D. , R. E. Schoonjans-k, . M. Lefebvre-a, N. J. Saladtn-r et al., The organization, promoter analysis, and expression of the human PPAR gamma gene, J Biol Chem, vol.272, pp.18779-89, 1997.

F. B. Tontonoz-p, C. J. Brl, R. P. Ln, and E. M. Spiegelman-b, 14)-prostaglandin j(2) is a ligand for the adipocyte determination factor PPAR gamma Cell, pp.803-815, 1995.

G. X. Wong-b, W. S. , and C. , Production of matrix metalloproteinase-9 in Caco2 cells in response to inflammatori stimuli, J Interferon Cytokine Res, pp.2-4, 2001.

G. L. Zhou-g, F. J. Fajas-l, and J. Auwerx, p300 interacts with the N-and C-terminal part of PPARgamma2 in a ligand-independent and -dependent manner, respectively, J Biol Chem, vol.274, pp.7681-7689, 1999.

G. M. Widmark-e, L. Q. , and G. J. , Fatty acids activate a chimera ofthe clofibric acid-activated receptor and the glucocorticoid receptor Proceedings ofthe National Academy ofSciences, pp.4653-4660, 1992.

G. M. , P. W. Plonka-p, P. S. Urbanska-k, L. P. , and S. , lnhibition of melanoma metastases by fenofibrate, Arch Dermatol Res, vol.296, pp.54-62, 2004.

G. M. Kwan-k and N. L. Greene-g, Isolation and cloning of human peroxisome proliferator activated receptor gamma cDNA, Adv Exp Med Biol, vol.400, pp.253-60, 1997.

G. S. Bellacosa-a, U. J. Klein-szanto, . Vanroy-f, . W. Lee-kwon, T. P. Donowitzm et al., The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines Cancer Res, pp.2172-2180, 2003.

G. H. Ishizuka-t, L. C. Chui-p, and L. M. , Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes, Genes Dev, vol.19, pp.453-61, 2005.

G. Y. Zhang-y, D. M. Breyer-r, and B. M. , Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death Neoplasia, pp.330-339, 1999.

G. R. Sarraf-p, . Mueller-e, P. J. Brockman-k, . Eng-c, . Willson-t et al., PPARI mediated differentiation: a mutation in colon cancer cells reveals divergent and cell-type specific mechanisms, J Biol Chem

H. S. Sidell-n and R. S. Roser-page, Fibronectin stimulates human lung carcinoma cell growth by inducing cyclooxygenase-2 (COX-2) expression

H. T. , C. T. Vogelstein-b, and K. , PPARô is an APC-regulated target of nonsteroidal anti-inflammatory drugs Cell, pp.335-380, 1999.

H. L. , K. S. Gibas-l, and S. A. Pietrzak-e, Gardner syndrome in a man with an interstitial deletion of 5q

H. M. Tsukamoto-t, S. J. Bourdeaux, and O. , Stabilization ofperoxisome proliferator-activated receptor alpha by the ligand, Biochem Biophys Res Commun

K. S. Forman-b, . Blumberg-b, . S. Ong-e, M. D. Borgmeyer-u, U. K. et al., Differential expression and activation of a family of murine peroxisome proliferator-activated receptor Proceedings ofthe National Academy ofSciences, pp.7355-7364, 1994.

K. D. Kressler-d and K. , Regulation of the transcriptional coactivator PGC-I via MAPK-sensitive interaction with a repressor, Proc Natl Acad Sci U S A, vol.98, pp.9713-9721, 2001.

K. H. Suzuki-r, S. S. , and T. , Suppression of colitis-relaûed mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands BMC Cancer, p.46, 2005.

K. K. Brûderlein-s, . Henne-c, L. M. Fletzt, and M. , Keratinocyte differentiation in hyperproliferative epidermis: topical application of PPARalpha activators restores tissue homeostasis, J Invest Dermatol, vol.115, pp.361-368, 2000.

K. A. Baeriswyl-v, . Lehembre-f, . Wtinderlin-c, A. H. Strittmatter-k, C. U. Fassler-r et al., Increased tumor cell dissemination and cellular senescence in the absence of betal -integrin function, Embo J, vol.26, pp.2832-2874, 2007.

K. A. Nielsen-c, S. N. , H. D. Helledie-t, . Thomsen-b, M. S. Bendixen-c et al., Nuclear receptor cor?pressor-dependent repression ofperoxisome-proliferator-activated receptor delta-mediated transactivatioon, Biochem J, vol.363, pp.157-65, 2002.

L. R. Meehan-w, . Xi-x, \. D. Graf-k, F. D. Coats-w, and H. , Troglitazone inhibits vascular smooth muscle cell growth and intimal hlperplasia, J Clin Invest, vol.98, pp.1897-905, 1996.

L. A. , C. I. Desreumaux-p, N. J. , F. J. Geboes-k, B. M. et al., Activation of the peroxisome proliferator-activated receptor T promotes the development of colon tumors, C5 78L/6J-APCMin/+mice Nat Med, pp.1053-1060, 1998.

L. B. Inouye-c, K. D. , and T. , Selectivity of chromatin-remodelling cofactors for ligand-activated ûanscription Nature, pp.924-932

L. R. Liu-j, . Gan-w, H. C. Wang-\ry, and . Liu-y, Fenofibrate inhibits tumor necrosis factor-alpha-induced expression of CIX0 and matrix metalloproteinase in human vascular endothelial cells

L. G. Turck-c, . Schaufele-f, and K. R. Stallcup-m, Growth factors signal to steroid receptors through mitogen-activated proûein kinase regulation ofpl60 coactivator activity, J Biol Chem, vol.276, pp.22177-82, 2001.

M. D. Thummel-c, H. P. Beato-m, . Schutz-g, . Umesomo-k, . Blumberg-b et al., The nuclear receptor superfamily: the second decade Cell, pp.835-844, 1995.

M. A. Guardiola-diaz-h, R. J. , B. C. , and G. J. , Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa, Biochem Biophys Res Commun, vol.222, pp.844-51, 1996.

M. G. Oraldi-m, T. A. Maggiora-m, C. R. Bertetto-o, and M. And, Involvement of PPARs in Cell Proliferation and Apoptosis in Human Colon Cancer Specimens and in Normal and Cancer Cell Lines PPAR Res, p.93416, 2007.

M. H. , A. H. Smart-r, A. J. Xu-x, and J. A. , Correlation between expression ofperoxisome proliferator-activaûed receptor beta and squamous differentiation in epidermal and facheobronchial epithelial cells, Mol cell Endoqinol, vol.147, pp.85-92, 1999.

M. C. Barak-y, M. I. , and C. R. , Intestinal-specific PPARgamma deficiency enhances tumorigenesis in ApcMir, IntJ Cancer, vol.19, pp.2339-2385, 2006.

M. L. Desvergne-b and T. S. Basu-modak, Nuclear hormone receptors and mouse skin homeostasis: implication of, PPARbeta Horm Res, vol.54, pp.263-271, 2000.

M. M. Wu, Z. , A. G. Puigserver-p, F. M. , and S. , Direct coupling of transcription and mRNA processing through the thermogenic coactivator PGC-I, Mol Cell, vol.6, pp.307-323, 2000.

M. E. , B. S. Kurtz-t, and P. , Effects of thiazolidinediones on growth and differentiation of human aorta and coronary myocytes, Am J Hypertens, vol.10, pp.440-446, 1997.

M. W. Nagamine-m, . Tanno-s, . M. Sav-/-amukai, K. Y. Takahashi-n, and O. , Inhibition of cell invasion and morphological change by troglitazone in human pancreatic cancer cells, J Gastroenterol, vol.39, pp.46-54, 2004.

M. H. , C. P. Huin-schohn, . N. Al-makdissy, C. A. Kerjan-g, D. M. Donner-m et al., Effects of PPAR and RXR ligands in semaphorin 68 gene expression of human MCF-7 breast cancer cells, Int J Oncol, vol.2, pp.977-84, 2006.

. Thiazolidinedione, apeorxisome proliferator-activated receptor-gamma ligand, modulates the E-cacherin/betacatenin system in a human pancreatic cancer cell line, p.3

P. B. Vogelstein-b and K. , Genetic disruption of PPARô decreases the tumorigenicity of human colon cancer cells Proceedings ofthe National Acadenry ofSciences, pp.2598-603, 2001.

P. P. , A. G. Wu-2, F. M. Xu-j, and S. B. Omalley-b, Activation of PPARgamma Coactivator-l through transcription factor docking Science, p.999

R. Y. Beneteau-n, C. V. Taillandier-t, . Lestienne-f, P. E. Dupont-passelaigue, C. F. et al., Cardiovascular drugs inhibit MMP-9 activity from human THP-I macrophages, DNA Cell Biol, vol.23, pp.283-92, 2004.

S. M. Herzberg-f, . Schmidt-r, . Streit-m, . Schôntng-m, . Hummel-m et al., Integrin c5Bl: a potent inhibitor of experimental lung metastasrs, Clin Exp Metastasis, vol.16, pp.427-462, 1998.

. Schmidt-4, R. S. Endo-n, S. D. Vogel-r, and R. G. , Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acid Molecular Endocrinologt, pp.1634-1638, 1992.

S. E. Vtllard-p, P. J. Pineau-t, . Maurel-p, . 8. Nguyen-q, M. P. Fallone-f et al., Evidence for a new human CYPIAI regulation pathway involving PPAR-alpha and 2 PPRE sites Gastroenterologt, pp.127-131, 2004.

S. D. , R. S. , B. S. , K. S. Reginato-m, and L. M. , Interdornain communication regulating ligand binding by PPAR-gamma, Nature, vol.396, pp.377-80, 1998.

S. T. , Y. H. Mcbride-o, and G. F. , cDNA cloning, chromosomal mapping, and functionnal characterization of the human peroxisome proliferatoractivated receptor, Biochemistry, vol.32, pp.5598-604, 1993.

S. T. Kojima-k, Y. K. , H. H. , and T. , Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells Gut, pp.658-64, 2002.

S. I. Bosman-f, R. P. Dorta-g, A. D. Blum-a, and S. , Differential expression of laminin-5 subunits and integrin receptors in human colorectal neoplasia, J Pathol, vol.185, pp.44-52, 1998.

S. W. Bush-c, C. S. , M. N. Fields-a, and T. , Differential expression, distribution, and function of PPAR-gamma in the proximal and distal colon, Physiol Genomics, vol.30, pp.342-53, 2007.

S. 8. Tsuno-n, K. J. Saito-s, Y. H. Osada-t, T. S. Tsuruo-t, and N. Shibata-y, Decreased synthesis of matrix metalloproteinase-7 and adhesion to the extracellular matrix proteins of human colon cancer cells treated with troglitazone Surg Today, pp.343-50, 2002.

T. N. Okumura-t, . Fujimoto-y, L. Ka\ryabata, and K. Y. , Activation of PPARgamma inhibis cell growth and induces apoptosis in human gastic cancer cells FEBS Lett, pp.135-144, 1999.

T. O. Yamamoto-h, N. C. Sugita-y, . Xu-x, . Tsujino-t, . Takemasa-i et al., Expression of PPARdelta in multistage carcinogenesis of the colorectum: implications of malignant cancer morphology, Br J Cancer, vol.95, pp.889-95, 2006.

T. N. Icre-g, M. A. Bordier-ten-heggeler, W. W. , and M. , The nuclear hormone receptor peroxisome proliferator-activated receptor beta/delta potentiates cell chemotactism, polarization, and migration, Mol Cell Biol, vol.27, pp.7161-75, 2007.

T. P. Hu-e and S. B. , Stimulation of adipogenesis in fibroblasts by PPARy2, a lipid-activated transcription factor Cell, pp.79-147, 1994.

T. P. Singer-s, . M. Forman-b, F. J. Sarraf-p, F. C. Brun-r, A. S. Mueller-e et al., Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor garnma and the retinoid X receptor, Proceedings of the National Academy of Sciences, I 997, pp.2-3

T. J. Aldridge-t, . Lambe-k, and W. Macdonald-n, Peroxisome proliferator-activated receptor-alpha and the pleiofopic responses to peroxisome proliferators, Arch Toxicol, vol.20, pp.377-86, 1998.

V. J. Hoekstra-h, Evolving management of colorectal cancer lVorldJ Gastroenterol, pp.3956-67, 2008.

W. J. Ana, Regulation of matrix metalloproteinase expression in tumor invasion FASEB, J, p.13, 1999.

X. H. , S. T. Montana-v, L. M. Shearer-b, and C. J. , Structural basis for antagonist-mediated recruitment of nuclear co-repressor by PPARa Nature, pp.4-5, 2002.

Y. Q. Hokland-m, B. J. Zhang-y, . Nannmark-u, S. C. \ryatkins, . H. Goldfarb-r et al., Tumorlocalization by adoptively transferred, interleukin-2-activated NK cells leads to destruction of wellestablished lung metastases, Int J Cancer, vol.105, pp.512-521, 2003.

Z. Y. , A. K. Huang-q, and R. S. Rao-m, Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver, Journal of Biological Chemistry, vol.268, pp.26817-26837, 1993.

Z. Y. Kan-l, . Qi-c, Y. S. Kanwar-y, and R. S. Rao-m, Isolation and characterization ofperoxisome proliferator-activated receptor (PPAR) interacting protein (PRIP) as a coactivator for PPAR, J Biol Chem, vol.275, pp.13510-13516, 2000.

Z. Y. Qi-c, C. W. , Y. A. Rao-m, and R. J. , Cloning and characterization of PIMT, a protein with a methyltransferase domain, which interacts with and enhances nuclear receptor coactivator PRIP function, Proc Natl Acad Sci U S A, vol.98, pp.10380-10385, 2001.

W. Wahli, P. Devchand, and A. Ijpenberg, Fatty Acids, Eicosanoids, and Hypolipidemic Agents Regulate Gene Expression Through Direct Binding to Peroxisome Proliferator-Activated Receptors, Adv E*p Med Biol, vol.447, pp.199-209, 1999.
DOI : 10.1007/978-1-4615-4861-4_19

S. Kliewer, K. Umesono, and D. Noonan, Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors, Nature, vol.358, issue.6389, pp.771-774, 1992.
DOI : 10.1038/358771a0

I. Isseman, R. Prince, and J. Tugwood, The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs, Journal of Molecular Endocrinology, vol.11, issue.1, pp.37-47, 1993.
DOI : 10.1677/jme.0.0110037

S. Drori, G. Girnun, and L. Tou, Hic-5 regulates an epithelial program mediated by PPAR??, Genes & Development, vol.19, issue.3, pp.362-375, 2005.
DOI : 10.1101/gad.1240705

L. Miènalit<, B. Desvergnes, and W. Whali, Peroxisome proliferator-activated receptors and cancer: complex stories, Nat Rev Cancer, vol.4, pp.6-70, 2004.

B. Beamer, C. Negri, and C. Yen, Chromosomal Localization and Partial Genomic Structure of the Human Peroxisome Proliferator Activated Receptor-Gamma (hPPAR??) Gene, Biochemical and Biophysical Research Communications, vol.233, issue.3, pp.756-759, 1997.
DOI : 10.1006/bbrc.1997.6540

A. Elbrecht, Y. Chen, and C. Cullinan, Molecular Cloning, Expression and Characterization of Human Peroxisome Proliferator Activated Receptors ??1 and ??2, Biochemical and Biophysical Research Communications, vol.224, issue.2, pp.431-437, 1996.
DOI : 10.1006/bbrc.1996.1044

L. Fajas, D. Auboeuf, and E. Raspe, T\e organization, promoter anâlysis, and expression of the human PPAR gamma gene, J Biol Chem, vol.212, pp.18779-18789, 1997.

L. Fajas, J. Fruchart, and J. Auwerx, PPAR??3 mRNA: a distinct PPAR?? mRNA subtype transcribed from an independent promoter, FEBS Letters, vol.272, issue.1-2, pp.55-60, 1998.
DOI : 10.1074/jbc.272.32.20230

H. Sundvold and L. S. , Identification of a Novel Peroxisome Proliferator-Activated Receptor (PPAR) ?? Promoter in Man and Transactivation by the Nuclear Receptor ROR??1, Biochemical and Biophysical Research Communications, vol.287, issue.2, pp.383-390, 2001.
DOI : 10.1006/bbrc.2001.5602

Y. Zhu, C. Qi, and J. Korenberg, Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms., Proceedings of the National Academy of Sciences, vol.92, issue.17, pp.7921-7925, 1995.
DOI : 10.1073/pnas.92.17.7921

J. Zhou, K. Wilson, and J. Medh, Genetic analysis of four novel peroxisome proliferator activated receptor-?? splice variants in monkey macrophages, Biochemical and Biophysical Research Communications, vol.293, issue.1, pp.27-31, 2002.
DOI : 10.1016/S0006-291X(02)00138-9

X. Wang, C. Southard, and M. Kilgore, The Increased Expression of Peroxisome Proliferator-Activated Receptor-??1 in Human Breast Cancer Is Mediated by Selective Promoter Usage, Cancer Research, vol.64, issue.16, pp.5592-5596
DOI : 10.1158/0008-5472.CAN-04-0043

Y. Chen, A. Jimenez, and J. Medh, Identification of novel PPARy-splice variants in human THP-l, Biochem Biophys Acta, vol.1759, pp.32-432

. Kalninaz, P. Zatrakin, and K. Silina, Alteration and regulation macrophages. splicing in cancer, Genes Chromosomes Cancer, vol.42, pp.342-357, 2005.

F. El-bouhtoury, J. Keller, and C. S. , Peroxisomal enzymes in normal and tumoral human breast, The Journal of Pathology, vol.26, issue.1, pp.27-35, 1992.
DOI : 10.1016/0014-2964(75)90149-8

P. Chomczynski and N. Sacchi, Single-step method of RNA isolation by acid guanidium-thiocyanate-phenol-chloroform extraction, Anal Biochem, vol.762, pp.156-59, 1987.

H. Aviv and P. Leder, Purification of biologically active globin messager RNA by chromatography o! oligo thymldylic âcid-cellulose, Proc Natl Acad Sci, vol.69, pp.4-8, 1972.

L. Domenjoud and G. Nussbaum, Genomic sequences of human protamines whose genes, PRM1 and PRM2, are clustered, Genomics, vol.8, issue.1, pp.127-133, 1990.
DOI : 10.1016/0888-7543(90)90234-L

A. Mansen, H. Guardioladiaz, and J. Rafter, Expression of the Peroxisome Proliferator-Activated Receptor (PPAR) in the Mouse Colonic Mucosa, Biochemical and Biophysical Research Communications, vol.222, issue.3, pp.844-851, 1996.
DOI : 10.1006/bbrc.1996.0832

E. Laemmli, Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4, Nature, vol.244, issue.5259, pp.680-685, 1970.
DOI : 10.1101/SQB.1963.028.01.053

H. Towbin, T. Staehelin, and G. J. , Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications., Proceedings of the National Academy of Sciences, vol.76, issue.9, pp.4350-4354
DOI : 10.1073/pnas.76.9.4350

M. Pinto, S. Robine-leon, and M. Appay, Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture, Biol Cell, vol.47, pp.323-330, 1983.

T. Lesuffleur, A. Barbat, and E. Dussaulx, Growth adaptation to methotrexate of HT29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells, Cancer Res, vol.50, pp.6334-6343

C. Huin, H. Schohn, and R. Hatier, Expression of peroxisome proliferator-activated receptors alpha and gamma in differentiating human colon carcinoma Caco-2 cells, Biology of the Cell, vol.94, issue.1, pp.15-27, 2002.
DOI : 10.1016/S0248-4900(01)01178-9

S. Hauser, G. Adelmant, and P. Sarraf, Degradation of the Peroxisome Proliferator-activated Receptor ?? Is Linked to Ligand-dependent Activation, Journal of Biological Chemistry, vol.112, issue.10, pp.18527-18533, 2000.
DOI : 10.1016/S1097-2765(00)80140-9

P. Salraf, E. Mueller, and D. Jones, Differentiation and reversal of malignant changes in colon cancer through PPARgamma, Nat Med, vol.4, pp.6-1052, 1998.

M. Kato, T. Kusumi, and S. Tsuchida, Induction of differentiation and peroxisome proliferator-activated receptor ? expression in colon cancer cell lines by troglitazone, Journal of Cancer Research and Clinical Oncology, vol.130, issue.2, pp.73-79
DOI : 10.1007/s00432-003-0510-2

D. Auboeuf, J. Rieusset, and L. Fajas, Tissue distribution and quantification of the expression of peroxisome proliferatoractivated receptors and I iver X receptor-q in humans: no alterations in adipose tissue and NIDDM patients, Diabetes, vol.46, pp.3-9, 1997.

F. Presence, . Ppart, . Variants, . Colon, R. Dubois et al., The nuclear eicosanoid receptor, PPARgarrrma, is aberrantly expressed in colonic cancers, Carcinogenesis, vol.19, pp.49-53, 1998.

A. Chawla, E. Schwartz, and D. Dimaculangan, Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation., Endocrinology, vol.135, issue.2, pp.798-800, 1994.
DOI : 10.1210/endo.135.2.8033830

P. Tontonoz, E. Hu, and B. Spiegelman, Stimulation of adipogenesis in fibroblasts by PPARy2, a lipid-activated transcription factor, Cell, vol.79, pp.47-156, 1994.

P. Thuillier, R. Baillie, and X. Sha, Cytosolic and nuclear distribution of PPARgamma2 in differentiating 3T3-Ll preadipocytes, J Lipid Res, vol.39, pp.2329-2338, 1999.

E. Sunami, N. Tsuno, and J. Kitayama, Decreased Synthesis of Matrix Metalloproteinase-7 and Adhesion to the Extracellular Matrix Proteins of Human Colon Cancer Cells Treated with Troglitazone, Surgery Today, vol.32, issue.4, pp.343-350, 2002.
DOI : 10.1007/s005950200049

S. Kitamura, Y. Miyazaki, and Y. Shinomura, Peroxisome Proliferator-activated Receptor ?? Induces Growth Arrest and Differentiation Markers of Human Colon Cancer Cells, Japanese Journal of Cancer Research, vol.222, issue.1, pp.75-80, 1999.
DOI : 10.1006/bbrc.1996.0832

A. Bull, K. Steffensen, and J. Laeers, Activation of PPAR ?? in colon tumor cell lines by oxidized metabolites of linoleic acid, endogenous ligands for PPAR ??, Carcinogenesis, vol.24, issue.11, pp.1717-1722
DOI : 10.1093/carcin/bgg131

M. Pritsker, T. Doniger, and L. Kramer, Diversification of stem cell molecular repertoire by alternative splicing, Proceedings of the National Academy of Sciences, vol.22, issue.5, pp.2-142962
DOI : 10.1634/stemcells.22-5-770

R. Brandenberger, H. Wei, and S. Zhang, Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation, Nature Biotechnology, vol.25, issue.Suppl., pp.707-716, 2004.
DOI : 10.1093/nar/25.17.3389

A. Pfeifer, K. Cole, and D. Smoot, Simian virus 40 large tumor antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogens., Proceedings of the National Academy of Sciences, vol.90, issue.11, pp.5123-5127, 1992.
DOI : 10.1073/pnas.90.11.5123

URL : http://www.pnas.org/content/90/11/5123.full.pdf